JAKARTA – PT Medikaloka Hermina Tbk (HEAL) is targeting revenue growth of 12%-15% in 2025 compared to 2024. This was reported by analyst PT BRI Danareksa Sekuritas (BRIDS) in HEAL’s Equity Research published on Monday (24/3).

Ismail Fakhri Suweleh, Analyst at BRIDS, stated that HEAL is aiming for revenue in the range of IDR 7.5 trillion to IDR 7.7 trillion in 2025. "This target is driven by the addition of 700 brownfield bed units and 200 greenfield bed units," he said in the analysis report.

Revenue growth will also come from contributions by private patients and non-hospital business segments.

In addition, HEAL is targeting a 100 basis point (bps) increase in EBITDA margin, while the net profit margin attributable to the owners of the entity is projected to remain stable at 8% compared to 2024.

The company posted a 22.54% increase in net profit in 2024 to IDR 535.94 billion, up from IDR 437.34 billion in 2023. Revenue rose by 16.13% to IDR 6.71 trillion from IDR 5.78 trillion. (LK/ZH)